Ventricular Assist Device Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Ventricular Assist Device Market Size Likely To Evolve From 2025 Through 2034?

The market concerning ventricular assist devices has experienced swift expansion lately, projected to increase its valuation from $2.12 billion in 2024 to $2.37 billion in 2025, reflecting an 11.8% compound annual growth rate; this upward trajectory during the past period stems from the heightened incidence of heart failure cases alongside growing requirements for organ replacement surgeries.

Anticipation surrounds the ventricular assist device sector, which projects substantial expansion in the forthcoming years, reaching a market valuation of $3.87 billion by 2029, reflecting a solid compound annual growth rate (CAGR) of 13.0%. This surge throughout the projection timeframe is fueled by a growing demand for destination therapy options, the expanding demographic of older adults, escalating healthcare spending globally, and heightened consciousness concerning therapeutic interventions for heart failure. Key developments anticipated during this period encompass efforts to enhance the longevity and operational effectiveness of VADs, the trend towards smaller device designs, the introduction of sophisticated pump mechanisms, placing greater emphasis on ensuring VAD safety and efficacy, initiatives aimed at mitigating associated adverse effects, and the advancement of ventricular assist devices that can be inserted via a needle puncture.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Industry Drivers Are Expected To Accelerate The Ventricular Assist Device Market From 2025 To 2029?

The escalating incidence of heart-related ailments is fueling the expansion of the market for ventricular assist devices. These cardiac conditions stem from various lifestyle and health-related issues, including elevated blood pressure, tobacco use, elevated cholesterol levels, sedentary habits, and other contributing elements. Furthermore, the rising frequency of cardiovascular diseases is compounded by chronic, non-communicable conditions such as diabetes, persistent respiratory ailments, and hypertensive episodes leading to heart attacks. Given that these devices offer crucial life support for patients suffering from advanced heart failure, the substantial rise in cardiovascular disease prevalence is anticipated to elevate the requirement for ventricular assist devices. To illustrate this trend, data from the US federal agency, the National Library of Medicine, indicated in October 2022 that projections estimate 45.1% of the American populace will be afflicted with cardiovascular disease by the year 2035, with the aggregate financial burden of these conditions projected to hit $1.1 trillion within that same year, hence creating a strong impetus for increased ventricular assist device adoption across the projected timeframe.

What Are The Major Segments Identified In The Ventricular Assist Device Market?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Trends Are Redefining The Ventricular Assist Device Market Dynamics?

The adoption of ventricular assist devices inserted via a percutaneous route is on the rise within the marketplace. This type of VAD functions using a non-pulsatile axial flow mechanism, situated across the aortic valve to propel blood originating from the left ventricle. Utilizing a percutaneously placed VAD results in a reduced strenuous demand on the left ventricle and a decrease in myocardial oxygen usage, consequently enhancing the volume of blood pumped by the heart and lowering the pressure at the conclusion of the left ventricle’s filling phase. By way of illustration, Abiomed Inc., a medical technology corporation headquartered in the United States, launched its Impella device, a percutaneous VAD, in August 2022, making it accessible for eligible pediatric populations across the US. This apparatus furnishes adequate circulatory assistance necessary to offset the function of a compromised left ventricle in patients, and furthermore, it is capable of substituting for support provided by extracorporeal membrane oxygenation (ECMO) or can be administered concurrently with other treatments to stabilize blood flow dynamics.

Which Major Industry Participants Are Leading The Ventricular Assist Device Market Growth?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Do Regional Market Performances Compare Within The Ventricular Assist Device Industry?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ventricular Assist Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795